Clarius Group, LLC Amgen Inc Transaction History

Clarius Group, LLC

$1.4 Billion
Q3 2024

A detailed history of Clarius Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Clarius Group, LLC holds 8,280 shares of AMGN stock, worth $2.17 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

8,280

Previous 8,411 1.56%

Holding current value

$2.17 Million

Previous $2.63 Million 1.48%

% of portfolio

0.19%

Previous 0.19%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$309.38 - $337.38 $40,528 - $44,196	-131 Reduced 1.56%	8,280 $2.67 Million
Q2 2024 Jul 11, 2024	SELL	$262.75 - $319.31 $60,169 - $73,121	-229 Reduced 2.65%	8,411 $2.63 Million
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $316,728 - $382,331	-1,178 Reduced 12.0%	8,640 $2.46 Million
Q4 2023 Jan 29, 2024	BUY	$255.7 - $288.46 $744,854 - $840,283	2,913 Added 42.19%	9,818 $2.83 Million
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $200,283 - $248,657	-916 Reduced 11.71%	6,905 $1.86 Million
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $64,923 - $76,771	303 Added 4.03%	7,821 $1.74 Million
Q1 2023 Apr 17, 2023	SELL	$225.79 - $275.2 $47,190 - $57,516	-209 Reduced 2.7%	7,518 $1.82 Million
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $32,751 - $41,614	143 Added 1.89%	7,727 $2.03 Million
Q3 2022 Oct 24, 2022	BUY	$224.46 - $253.15 $41,974 - $47,339	187 Added 2.53%	7,584 $1.71 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $75,672 - $84,210	328 Added 4.64%	7,397 $1.8 Million
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $26,053 - $29,815	131 Added 1.89%	7,069 $1.59 Million
Q3 2021 Oct 18, 2021	SELL	$212.27 - $248.7 $75,568 - $88,537	-356 Reduced 4.88%	6,938 $1.48 Million
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $934 - $1,036	4 Added 0.05%	7,294 $1.78 Million
Q1 2021 Apr 27, 2021	BUY	$221.91 - $258.6 $100,747 - $117,404	454 Added 6.64%	7,290 $1.81 Million
Q4 2020 Jan 15, 2021	BUY	$216.38 - $257.67 $129,611 - $154,344	599 Added 9.6%	6,836 $1.57 Million
Q3 2020 Oct 09, 2020	BUY	$234.65 - $260.95 $8,447 - $9,394	36 Added 0.58%	6,237 $1.59 Million
Q2 2020 Jul 08, 2020	BUY	$197.81 - $242.74 $147,961 - $181,569	748 Added 13.72%	6,201 $1.46 Million
Q1 2020 Apr 24, 2020	SELL	$182.24 - $241.7 $29,522 - $39,155	-162 Reduced 2.89%	5,453 $1.11 Million
Q4 2019 Jan 22, 2020	BUY	$189.21 - $243.2 $50,708 - $65,177	268 Added 5.01%	5,615 $1.36 Million
Q3 2019 Oct 23, 2019	BUY	$174.11 - $208.62 $190,650 - $228,438	1,095 Added 25.75%	5,347 $1.04 Million
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $53,677 - $62,922	322 Added 8.19%	4,252 $784,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $177,071 - $199,598	979 Added 33.18%	3,930 $747,000
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $85,632 - $99,960	480 Added 19.43%	2,951 $574,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $224,756 - $253,383	1,213 Added 96.42%	2,471 $512,000
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $210,450 - $240,278	1,258	1,258 $235,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Amgen Inc Transaction History